SeaStar Medical (ICU) vs Quantum Biopharma (QNTM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SeaStar Medical (ICU) has outperformed Quantum Biopharma (QNTM) over the past year, losing 47.0% versus a loss of 80.3%. Over five years, QNTM leads with a -96.7% price change compared with -99.9% for ICU. Quantum Biopharma is the larger company by market cap ($20.0 million vs $18.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICU | QNTM |
|---|---|---|
| Share price | $3.49 | $3.11 |
| Market cap | $18.36M | $20.00M |
| 1-day change | -6.18% | -1.11% |
| YTD return | +45.42% | -57.40% |
| 1-year return | -47.04% | -80.28% |
| 5-year return | -99.86% | -96.65% |
| EPS (TTM) | $-2.97 | $-4.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.35 | $16.36 |
| 52-week low | $2.07 | $2.07 |
| Distance from 52-week high | -52.52% | -80.99% |
| Analyst consensus | none | none |
| Avg. price target upside | +186.53% | +294.53% |
| Average volume | 99.80K | 205.30K |
| Shares outstanding | 5.26M | 6.43M |
| Employees | 18 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICU has outperformed QNTM by 33.2 percentage points over the past year.
About SeaStar Medical
ICU stock →SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.
Healthcare · Biotechnology · 18 employees
About Quantum Biopharma
QNTM stock →Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments.
Healthcare · Biotechnology
ICU vs QNTM FAQ
Which is bigger, SeaStar Medical or Quantum Biopharma?
Quantum Biopharma (QNTM) is larger, with a market capitalization of $20.00M compared with $18.36M for SeaStar Medical (ICU).
Which stock has performed better over the past year, ICU or QNTM?
ICU returned -47.04% over the past 12 months, compared with -80.28% for QNTM (price return, excluding dividends). Past performance does not predict future results.
Are SeaStar Medical and Quantum Biopharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.